TGA business plan 2024-25
The Therapeutic Goods Administration (TGA), as part of the Australian Government Department of Health and Aged Care, is responsible for ensuring that therapeutic goods available for supply in Australia are safe, effective, and fit for their intended purpose. These include everyday goods such as analgesics and sunscreens, as well as those used to treat and prevent serious conditions like prescription medicines, vaccines, blood products, and surgical implants.
The TGA Business Plan 2024-25 outlines our strategic direction and priorities for promoting public health outcomes through efficient regulatory measures. It details our core business activities, including the regulation of medicines, medical devices, blood and blood products, and biologicals. This plan also addresses emerging technologies, digital transformation initiatives, and key regulatory reforms, including those related to vaping products.
Contents
- Message from the Deputy Secretary
- Our purpose
- Our vision
- Our strategic intent
- Our strategic objectives
- Reporting